Effects of dosage titration of methylprednisolone acetate and triamcinolone acetonide on interleukin-1-conditioned equine articular cartilage explants in vitro
Osteoarthritis is a frequent sequela of joint disease, especially with severe injuries or if attempts at therapy are unsuccessful. Negative and positive effects of corticosteroid treatment of articular cartilage have been demonstrated by in vitro and in vivo studies. To assess the metabolic effects...
Saved in:
Published in | Equine veterinary journal Vol. 35; no. 5; p. 444 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
United States
01.07.2003
|
Subjects | |
Online Access | Get more information |
Cover
Loading…
Abstract | Osteoarthritis is a frequent sequela of joint disease, especially with severe injuries or if attempts at therapy are unsuccessful. Negative and positive effects of corticosteroid treatment of articular cartilage have been demonstrated by in vitro and in vivo studies.
To assess the metabolic effects of varying dosages of methylprednisolone acetate (MPA) and triamcinolone acetonide (TA) on interleukin-1alpha (IL-1) conditioned equine cartilage explants. Our hypothesis was that lower dosages of corticosteroids would be less detrimental to cartilage metabolism than higher dosages. TA would be less detrimental to cartilage metabolism than MPA.
Treatment groups included articular cartilage explants with no IL-1 (control), IL-1 alone, and IL-1 plus 10, 5, 1 and 0.5 mg/ml MPA or 1.2, 0.6, 0.12 and 0.06 mg/ml TA. Explants were labelled with 35SO4 prior to the beginning and end of the experiment to assess glycosaminoglycan (GAG) degradation and synthesis, respectively. Total GAG content in media and explants and total cartilage DNA were also analysed.
MPA and TA reduced GAG synthesis compared to control and IL-1 alone. The highest dosage of MPA (10 mg/ml) reduced GAG synthesis less than lower dosages of MPA and all dosages of TA. Compared to IL-1 alone, all dosages of TA and lower dosages of MPA increased GAG degradation. MPA at 10 mg/ml reduced GAG degradation. Both MPA and TA increased media GAG content compared to control and IL-1 explants. Total cartilage GAGs were unchanged with MPA, but reduced with TA, compared with IL-1 alone. Total cartilage DNA was decreased with MPA and increased with TA compared to IL-1 and control explants.
MPA and TA did not counteract the negative effects of IL-1 and did not maintain cartilage metabolism at control levels. Lower dosages of MPA and TA were not less detrimental to cartilage metabolism than higher dosages. TA did not appear to be less harmful than MPA on cartilage metabolism. The results of this study differ from the findings of comparable in vivo studies.
The low numbers of horses used in this study limits extrapolation of these findings to the equine population; however, this study also questions the clinical relevance of this in vitro model. |
---|---|
AbstractList | Osteoarthritis is a frequent sequela of joint disease, especially with severe injuries or if attempts at therapy are unsuccessful. Negative and positive effects of corticosteroid treatment of articular cartilage have been demonstrated by in vitro and in vivo studies.
To assess the metabolic effects of varying dosages of methylprednisolone acetate (MPA) and triamcinolone acetonide (TA) on interleukin-1alpha (IL-1) conditioned equine cartilage explants. Our hypothesis was that lower dosages of corticosteroids would be less detrimental to cartilage metabolism than higher dosages. TA would be less detrimental to cartilage metabolism than MPA.
Treatment groups included articular cartilage explants with no IL-1 (control), IL-1 alone, and IL-1 plus 10, 5, 1 and 0.5 mg/ml MPA or 1.2, 0.6, 0.12 and 0.06 mg/ml TA. Explants were labelled with 35SO4 prior to the beginning and end of the experiment to assess glycosaminoglycan (GAG) degradation and synthesis, respectively. Total GAG content in media and explants and total cartilage DNA were also analysed.
MPA and TA reduced GAG synthesis compared to control and IL-1 alone. The highest dosage of MPA (10 mg/ml) reduced GAG synthesis less than lower dosages of MPA and all dosages of TA. Compared to IL-1 alone, all dosages of TA and lower dosages of MPA increased GAG degradation. MPA at 10 mg/ml reduced GAG degradation. Both MPA and TA increased media GAG content compared to control and IL-1 explants. Total cartilage GAGs were unchanged with MPA, but reduced with TA, compared with IL-1 alone. Total cartilage DNA was decreased with MPA and increased with TA compared to IL-1 and control explants.
MPA and TA did not counteract the negative effects of IL-1 and did not maintain cartilage metabolism at control levels. Lower dosages of MPA and TA were not less detrimental to cartilage metabolism than higher dosages. TA did not appear to be less harmful than MPA on cartilage metabolism. The results of this study differ from the findings of comparable in vivo studies.
The low numbers of horses used in this study limits extrapolation of these findings to the equine population; however, this study also questions the clinical relevance of this in vitro model. |
Author | Dechant, J E Frisbie, D D Trotter, G W McIlwraith, C W Baxter, G M |
Author_xml | – sequence: 1 givenname: J E surname: Dechant fullname: Dechant, J E organization: Equine Orthopaedic Research Laboratory, Department of Clinical Sciences, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, Colorado 80523, USA – sequence: 2 givenname: G M surname: Baxter fullname: Baxter, G M – sequence: 3 givenname: D D surname: Frisbie fullname: Frisbie, D D – sequence: 4 givenname: G W surname: Trotter fullname: Trotter, G W – sequence: 5 givenname: C W surname: McIlwraith fullname: McIlwraith, C W |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/12875321$$D View this record in MEDLINE/PubMed |
BookMark | eNpFUMtOwzAQtFARfcAPcED-gYBfcdIjqspDqsQFzpXj3YAhsYPjIPo1_CqJAHGa1ezszGiXZOaDR0LOObsUhdJXTImca8VkUeSaMVWsj8hCjGwmJdMzspgE2ahQc7Ls-1fGpBRKnJA5F2WRS8EX5Gtb12hTT0NNIfTmGWlyKZrkgp-4FtPLoekignd9aMYC1FhMJo3ogaboTGud_98E7wDpeOx8wtjg8OZ8xjMbPLjJFIHi--AmdUzODo2J1E5jM2XjZ9cYP9Zxnn6MPcIpOa5N0-PZL67I0832cXOX7R5u7zfXu8zKUunMFqwCW5VY1dUaUAupoBAAFSLUJhecacz5GvXaABhhhS2tQs54xaWFEsWKXPz4dkPVIuy76FoTD_u_T4lvoW1zlA |
CitedBy_id | crossref_primary_10_1111_j_2042_3306_2010_00095_x crossref_primary_10_1111_j_2042_3306_2010_00324_x crossref_primary_10_1186_s12891_017_1743_6 crossref_primary_10_1007_s11626_016_0022_4 crossref_primary_10_1038_sj_gt_3302757 crossref_primary_10_2746_0425164044864615 crossref_primary_10_1002_jor_23568 crossref_primary_10_3389_fvets_2020_00486 crossref_primary_10_3389_fvets_2020_00323 crossref_primary_10_1111_evj_13396 crossref_primary_10_1016_j_mtbio_2019_100023 crossref_primary_10_1002_msc_1145 crossref_primary_10_1097_ICO_0b013e318030d230 crossref_primary_10_1016_j_orthres_2004_10_003 crossref_primary_10_1186_s13028_019_0464_2 crossref_primary_10_2460_ajvr_82_2_125 crossref_primary_10_1111_vsu_13898 crossref_primary_10_2460_ajvr_2005_66_48 crossref_primary_10_1016_j_jevs_2022_104143 crossref_primary_10_1016_j_jevs_2007_05_006 crossref_primary_10_1002_jbm_a_32589 crossref_primary_10_2746_0425164054530687 crossref_primary_10_1089_scd_2022_0074 crossref_primary_10_3389_fvets_2017_00152 crossref_primary_10_1111_j_1532_950X_2012_01025_x |
ContentType | Journal Article |
DBID | CGR CUY CVF ECM EIF NPM |
DOI | 10.2746/042516403775600479 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) |
DatabaseTitleList | MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | no_fulltext_linktorsrc |
Discipline | Veterinary Medicine |
EISSN | 2042-3306 |
ExternalDocumentID | 12875321 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- .GA .Y3 05W 0R~ 1OB 1OC 29G 31~ 33P 3SF 4.4 50Y 50Z 52M 52U 53G 5GY 8-0 8-1 8-3 8-4 8-5 930 A03 AAESR AAEVG AAHHS AANLZ AAONW AASGY AAVBQ AAXRX AAZKR ABCUV ABJNI ABPVW ACAHQ ACBWZ ACCFJ ACCZN ACFBH ACGFS ACPOU ACSMX ACXBN ACXME ACXQS ADBBV ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZMN ADZOD AEEZP AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFFPM AFGKR AFPWT AFRAH AFZJQ AHBTC AHMBA AI. AIURR AIWBW AJBDE AJXKR ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB ASPBG ATUGU AUFTA AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMNLL BMXJE BNHUX BRXPI C45 CAG CGR COF CS3 CUY CVF D-E D-F DCZOG DPXWK DRFUL DRSTM DU5 EBS ECGQY ECM EIF EJD EYRJQ F00 F01 F04 F5P FEDTE G-S GODZA H.T H.X HF~ HGLYW HVGLF HVLQZ HZ~ LATKE LEEKS LH4 LITHE LOXES LUTES LW6 LYRES MEWTI MRFUL MRSTM MSFUL MSSTM MXFUL MXSTM MY~ N04 N05 N9A NF~ NNB NPM O66 OVD P2P P2W P2X P4E PALCI PQQKQ Q.N QB0 R.K RIWAO RJQFR ROL RWI RX1 SAMSI SUPJJ TEORI UB1 VH1 W8V WBKPD WIH WIK WOHZO WOIKV WPGGZ WXSBR XG2 XV2 ZZTAW ~WT |
ID | FETCH-LOGICAL-c3846-c70bdcb8ebfb9de6234d72ddbeedfa52106e519e69adda2c2c8c4e101b13cd8e2 |
ISSN | 0425-1644 |
IngestDate | Thu May 23 23:55:12 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 5 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c3846-c70bdcb8ebfb9de6234d72ddbeedfa52106e519e69adda2c2c8c4e101b13cd8e2 |
PMID | 12875321 |
ParticipantIDs | pubmed_primary_12875321 |
PublicationCentury | 2000 |
PublicationDate | July 2003 |
PublicationDateYYYYMMDD | 2003-07-01 |
PublicationDate_xml | – month: 07 year: 2003 text: July 2003 |
PublicationDecade | 2000 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Equine veterinary journal |
PublicationTitleAlternate | Equine Vet J |
PublicationYear | 2003 |
SSID | ssj0033242 |
Score | 1.9079982 |
Snippet | Osteoarthritis is a frequent sequela of joint disease, especially with severe injuries or if attempts at therapy are unsuccessful. Negative and positive... |
SourceID | pubmed |
SourceType | Index Database |
StartPage | 444 |
SubjectTerms | Animals Anti-Inflammatory Agents - pharmacology Cartilage, Articular - drug effects Cartilage, Articular - metabolism Culture Techniques DNA - metabolism Dose-Response Relationship, Drug Glycosaminoglycans - analysis Glycosaminoglycans - metabolism Horse Diseases - drug therapy Horses Interleukin-1 - metabolism Male Methylprednisolone - analogs & derivatives Methylprednisolone - pharmacology Methylprednisolone Acetate Osteoarthritis - drug therapy Osteoarthritis - veterinary Triamcinolone Acetonide - pharmacology |
Title | Effects of dosage titration of methylprednisolone acetate and triamcinolone acetonide on interleukin-1-conditioned equine articular cartilage explants in vitro |
URI | https://www.ncbi.nlm.nih.gov/pubmed/12875321 |
Volume | 35 |
hasFullText | |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LbxMxELZSuHBBUN4tyAduq4XN2vvIEZWWCqk9pdBbFT9Wikh30yipSv9Mf1P_Ed_Y-0pKEXBZrezY6935Mv7Gnhkz9n5ERkYxzEMpijjEnQhzJW2ohDSRsoktBEUjHx2nhyfy62lyOhjc9ryWVkv1QV__Nq7kf6SKMsiVomT_QbJtpyjAPeSLKySM61_JeL9zxjAVeYgFKF-0JJBOh_45my-sKacYSFVS6gxyL_RbBnRgx7mell0N_t_GBs75kRw97erHtITxB5PZ-JRGJrAXK-KlbjDOg1XT7Yyeba_mM-dVMy2DS4yjWlv19-0uyfvGhwD335CYtKUYZL8zEvTSf17VJ4d86dZtD6CYlN9X-dx5LI8X1bL97fe11QzRer42Sg86JIQJ5xcZrCuLKYRIiCjta22f5KRGZ9JTwdK33ZwaYH27nSr0j-4jkWXE9aQ_yaaHlfm5AwumbRhyPnj7z7Ub6bqbqi22leWkco9p-chTA0HslahB85I-iouG9vHuwCifbd3Zhs3juM_4CXtcGy38k0fgUzaw5Tbb_tbKkh_VHhrP2E2NSV4V3GOSt5iksruY5DUmOTDJ1zDJW0xyNL4Xk9xjkreY5C0meYNJtOYOk8_ZycH-eO8wrA8BCbUANw51FimjVW5VoUbGgq1Lk8XGKJC7YgLyGaUWVohNR5ipJ7GOda6lxUSjhkKb3MYv2IMSg3nFeJKB305AyUyayKHO8kSJPEmLZAS7Rk_ka_bSf-Wzuc_0ctZ8_zf31uywRx2Md9nDAqrFvgVPXap3Tva_AE_UmAU |
link.rule.ids | 786 |
linkProvider | National Library of Medicine |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Effects+of+dosage+titration+of+methylprednisolone+acetate+and+triamcinolone+acetonide+on+interleukin-1-conditioned+equine+articular+cartilage+explants+in+vitro&rft.jtitle=Equine+veterinary+journal&rft.au=Dechant%2C+J+E&rft.au=Baxter%2C+G+M&rft.au=Frisbie%2C+D+D&rft.au=Trotter%2C+G+W&rft.date=2003-07-01&rft.issn=0425-1644&rft.eissn=2042-3306&rft.volume=35&rft.issue=5&rft.spage=444&rft_id=info:doi/10.2746%2F042516403775600479&rft_id=info%3Apmid%2F12875321&rft_id=info%3Apmid%2F12875321&rft.externalDocID=12875321 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0425-1644&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0425-1644&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0425-1644&client=summon |